Related Experiment Video
Updated: Jan 16, 2026
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
High-order single-nucleotide polymorphism interactions between selected anti-oxidant and protease genes influence
Heena Kansal1, Vishal Chopra2, Kranti Garg2
1Department of Biotechnology, Thapar Institute of Engineering & Technology, Patiala, 147004, Punjab, India.
Background:
COPD causes persistent airflow restriction, oxidative stress, and inflammation. Proteins like MMP9, MMP12, and ADAM33, and antioxidant enzymes such as Glutathione Peroxidase, Superoxide Dismutase, and Catalase are crucial for lung homeostasis, and imbalances increase COPD risk.
Methods:
A case-control study was carried out with 500 healthy controls and 500 COPD patients. We did genotype on several SNPs in CAT, SOD1, SOD2, GPx, MMP9, MMP12, and ADAM33, and further MDR, CART, and logistic regression models were applied to examine gene-gene interactions, pulmonary function tests, and clinical symptoms.
Results:
SNPs associated with higher COPD risk were SOD2 rs4880, CAT rs1001179, MMP9 rs17576, and ADAM33 rs612709. High-order combinations like SOD2 rs4880 and ADAM33 rs612709 (AOR = 1.44, p = 0.0001) and CAT rs1001179 and ADAM33 rs2280091 (AOR = 1.4, p = 0.0009) showed combinatorial effects. The risk of mucus was greatly lowered by numerous SOD2-based combinations, such as ADAM33 rs2280091, MMP9 rs17576, and MMP12 rs2276109. FEV1, FVC, and FEV1/FVC revealed genotype-specific disparities before and after bronchodilator usage. Combinations of SOD2 rs4880, ADAM33 rs612709, and MMP9 rs3918242 changed bronchodilator responses. MDR study exhibited that CAT (rs7943316) was the best single-locus model for risk prediction towards COPD patients. CART analysis showed SOD2 (rs4880) to be a disease risk factor.
Conclusion:
This study is the first to show high-order interactions between selected antioxidant and protease gene variations affecting COPD risk and lung function, specifically SOD2 rs4880, CAT rs1001179, and ADAM33 rs612709. The findings support the potential use of combinatorial genetic profiles in risk stratification and personalized therapeutic strategies for COPD.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:05Single Nucleotide Polymorphisms-SNPs
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...